BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29602696)

  • 21. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
    Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.
    Harlaar NJ; Koller M; de Jongh SJ; van Leeuwen BL; Hemmer PH; Kruijff S; van Ginkel RJ; Been LB; de Jong JS; Kats-Ugurlu G; Linssen MD; Jorritsma-Smit A; van Oosten M; Nagengast WB; Ntziachristos V; van Dam GM
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):283-290. PubMed ID: 28404198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement.
    de Bree E; Koops W; Kröger R; van Ruth S; Witkamp AJ; Zoetmulder FA
    J Surg Oncol; 2004 May; 86(2):64-73. PubMed ID: 15112247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery.
    Gadelhak B; Tawfik AM; Saleh GA; Batouty NM; Sobh DM; Hamdy O; Refky B
    Abdom Radiol (NY); 2019 Jun; 44(6):2254-2261. PubMed ID: 30788559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
    Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
    Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The accuracy of multi-detector computed tomography and laparoscopy in the prediction of peritoneal carcinomatosis index score in primary ovarian cancer.
    Ahmed SA; Abou-Taleb H; Yehia A; El Malek NAA; Siefeldein GS; Badary DM; Jabir MA
    Acad Radiol; 2019 Dec; 26(12):1650-1658. PubMed ID: 31101436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis.
    Laghi A; Bellini D; Rengo M; Accarpio F; Caruso D; Biacchi D; Di Giorgio A; Sammartino P
    Radiol Med; 2017 Jan; 122(1):1-15. PubMed ID: 27647163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT-Enteroclysis in the preoperative assessment of the small-bowel involvement in patients with peritoneal carcinomatosis, candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Courcoutsakis N; Tentes AA; Astrinakis E; Zezos P; Prassopoulos P
    Abdom Imaging; 2013 Feb; 38(1):56-63. PubMed ID: 22410875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
    Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
    World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?
    Cortes-Guiral D; Elias D; Cascales-Campos PA; Badía Yébenes A; Guijo Castellano I; León Carbonero AI; Martín Valadés JI; Garcia-Foncillas J; Garcia-Olmo D
    World J Gastroenterol; 2017 Jan; 23(3):377-381. PubMed ID: 28210074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Viganò L; Lopci E; Costa G; Rodari M; Poretti D; Pedicini V; Solbiati L; Chiti A; Torzilli G
    Ann Surg Oncol; 2017 Apr; 24(4):1029-1036. PubMed ID: 27807727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer.
    Hompes D; Aalbers A; Boot H; van Velthuysen ML; Vogel W; Prevoo W; van Tinteren H; Verwaal V
    Colorectal Dis; 2014 Aug; 16(8):O264-72. PubMed ID: 24433532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.
    Koh JL; Yan TD; Glenn D; Morris DL
    Ann Surg Oncol; 2009 Feb; 16(2):327-33. PubMed ID: 19050972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can [
    Elekonawo FMK; Starremans B; Laurens ST; Bremers AJA; de Wilt JHW; Heijmen L; de Geus-Oei LF
    Abdom Radiol (NY); 2020 Feb; 45(2):301-306. PubMed ID: 31642963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of peritoneal carcinomatosis.
    González-Moreno S; González-Bayón L; Ortega-Pérez G; González-Hernando C
    Cancer J; 2009; 15(3):184-9. PubMed ID: 19556902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
    Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
    Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
    Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
    Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.